Figure 7D,I depict the robust nuclear expression of P53 in the PHZ-induced colon cancer group compared to the control group. Nevertheless, treatment with AP and P alone or in combination, as well as the prophylactic approach with PHZ, significantly reduced the expression of the P53 protein (Figure 7E–I). Here, TP53 is linked to malignant colon neoplasm.